display
Brussels / Erlangen (dpa / lby) - EU competition watchdogs have approved the planned takeover of the US cancer specialist Varian by the medical technology group Siemens Healthineers, subject to conditions.
If Siemens and Varian adhere to the conditions, the merger would not pose a threat to competition, the EU Commissioner responsible Margrethe Vestager announced on Friday.
For example, companies have to commit to ensuring that their systems are compatible with those of other manufacturers.
But the project is not yet completely finished.
"It's an important step, but not the last," said a spokesman for Siemens Healthineers in Erlangen.
There are still other permits pending, for example in China.
The US control authority for foreign investments in the USA (CFIUS) had already approved the planned merger in November.
There were no national security concerns.
Siemens Healthineers intends to secure the merger with Varian by the middle of the year.
display
© dpa-infocom, dpa: 210219-99-513050 / 2